InvestorsHub Logo
Followers 7
Posts 1226
Boards Moderated 0
Alias Born 04/04/2012

Re: whyfuse post# 45820

Tuesday, 06/04/2013 10:12:48 AM

Tuesday, June 04, 2013 10:12:48 AM

Post# of 92285
The difference is right in the PR

"During the Company's Round I Research conducted in 2012, caffeine was delivered effectively through the epidermis. This initial study provided four basic principles surrounding Fuse Science's proprietary technology: speed, variability, duration and functionality.

The Round II Research results released May 31, 2013 expanded the prior proof of concepts by showing Fuse's proprietary delivery technology successfully delivering numerous Active Pharmaceutical Ingredients ("API's") of varying size, rigidity and lipophilicity, whether it is fat or water soluble, directly through the epidermis."